Numeric Investors’s Teva Pharmaceuticals TEVA Stock Holding History

Numeric Investors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-26,400	Closed	-$1.22M	–	1179
2016 Q3	$1.22M	Buy	26,400 +4,800	+22%	+$250K	0.01%	565
2016 Q2	$1.08M	Sell	21,600 -37,100	-63%	-$1.98M	0.01%	563
2016 Q1	$3.14M	Hold	58,700	–	–	0.03%	363
2015 Q4	$3.85M	Sell	58,700 -18,300	-24%	-$1.13M	0.04%	336
2015 Q3	$4.35M	Buy	77,000 +48,700	+172%	+$3.16M	0.05%	262
2015 Q2	$1.67M	Buy	28,300 +3,400	+14%	+$210K	0.02%	408
2015 Q1	$1.55M	Sell	24,900 -800	-3%	-$46.5K	0.02%	391
2014 Q4	$1.48M	Sell	25,700 -23,270	-48%	-$1.3M	0.02%	385
2014 Q3	$2.63M	Buy	+48,970	New	+$2.59M	0.04%	300

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Numeric Investors's TEVA Position: Q4 2016 in Review

Numeric Investors sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 26,400 shares — an estimated $1.22M sold.

Numeric Investors first reported a position in TEVA in Q3 2014 and held it in 9 quarters. The position peaked at $4.35M in Q3 2015. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Numeric Investors reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Numeric Investors sold 26,400 Teva Pharmaceuticals shares in Q4 2016, an estimated $1.22M.
Numeric Investors first reported a position in Teva Pharmaceuticals in Q3 2014 and held it in 9 quarters.
Numeric Investors's Teva Pharmaceuticals position peaked at $4.35M in Q3 2015.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Numeric Investors's 13F filing for Q4 2016, filed 13 Feb 2017.